06/05/2024
3:22 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/04/2024
4:27 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
4:20 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
2:36 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
2:20 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
2:11 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/30/2024
3:36 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:34 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
3:12 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
2:12 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
2:14 PM | Garay Arpa (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
2:20 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
2:22 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
2:21 PM | Mock James M (Reporting)
Mock James M (Reporting)
Moderna (Subject)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
2:21 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:27 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
3:23 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024
12:41 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2024
3:03 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
3:43 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024
3:24 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
3:51 PM | LANGER ROBERT (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:54 PM | Horning Sandra (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:57 PM | Moderna (Issuer)
Tallett Elizabeth E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:59 PM | Moderna (Issuer)
SAGAN PAUL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
4:02 PM | Moderna (Issuer)
Nader Francois (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:42 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
5:31 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2024
3:21 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/19/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:17 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024
3:23 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
9:58 AM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/12/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:22 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
AI Hell Will Break Loose [June 30, 2024] … (Ad) On June 30, 2024, AI will reach a critical tipping point…
Whatever you do, make sure you prepare before June 30 at the very latest. Watch this now to find out why. |
04/10/2024
1:03 PM | Moderna (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
04/09/2024
3:09 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
2:32 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
3:20 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/29/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
3:22 PM | AFEYAN NOUBAR (Reporting)
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/22/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
7:46 AM | Moderna (Filer)
| Form DEF 14A | |
03/21/2024
7:47 AM | Moderna (Filer)
| Form DEFA14A | |
03/19/2024
3:39 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
11:12 AM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
8:30 AM | Moderna (Filer)
| Form ARS | |
03/13/2024
3:24 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
8:05 AM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
2:22 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
2:13 PM | Garay Arpa (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
4:52 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
2:32 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
2:25 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:25 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:29 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:33 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:28 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
3:49 PM | Garay Arpa (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
3:32 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:37 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:39 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:24 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
3:21 PM | Moderna (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/22/2024
2:39 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024
5:32 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
3:20 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
2:16 PM | Bancel Stephane (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
2:39 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024
7:42 AM | Bancel Stephane (Filed by)
Moderna (Subject)
| Form SC 13G/A | |
01/29/2024
2:26 PM | BlackRock Inc. (Filed by)
Moderna (Subject)
| Form SC 13G/A | |
01/29/2024
9:49 AM | BAILLIE GIFFORD & CO (Filed by)
Moderna (Subject)
| Form SC 13G/A | |
01/08/2024
2:21 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
6:03 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
7:00 AM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
10:37 AM | Hoge Stephen (Reporting)
Moderna (Subject)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
7:04 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
2:24 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/07/2023
3:21 PM | Garay Arpa (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
2:13 PM | Garay Arpa (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023
2:43 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023
2:30 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023
2:35 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Why June 30 Will Be the Tipping Point for AI (Ad) AI is already replacing workers in warehouses.
It’s spreading like lightning in the software, legal and engineering industries…
It’s now estimated at least 300 million jobs worldwide are in AI’s crosshairs. Click here for details. |
11/13/2023
7:54 AM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023
7:02 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
5:33 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/27/2023
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2023
7:59 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/13/2023
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2023
3:07 PM | Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2023
3:07 PM | AFEYAN NOUBAR (Reporting)
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
